| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 911.64B | 796.67B | 788.87B | 938.10B | 865.17B |
| Gross Profit | 191.29B | 172.78B | 165.25B | 191.06B | 169.73B |
| EBITDA | 85.52B | 84.11B | 83.18B | 93.68B | 88.22B |
| Net Income | 22.87B | 10.65B | 8.50B | 18.41B | 16.59B |
Balance Sheet | |||||
| Total Assets | 1.24T | 1.22T | 1.30T | 1.23T | 1.23T |
| Cash, Cash Equivalents and Short-Term Investments | 142.12B | 198.51B | 191.99B | 161.45B | 139.01B |
| Total Debt | 219.11B | 329.03B | 342.61B | 360.81B | 327.21B |
| Total Liabilities | 547.63B | 550.35B | 620.12B | 598.53B | 597.09B |
| Stockholders Equity | 671.98B | 651.46B | 659.98B | 616.21B | 617.80B |
Cash Flow | |||||
| Free Cash Flow | 59.77B | 44.05B | 49.88B | 19.87B | -13.33B |
| Operating Cash Flow | 97.81B | 82.18B | 99.82B | 64.16B | 22.73B |
| Investing Cash Flow | -64.75B | -58.75B | -90.81B | -48.78B | -19.97B |
| Financing Cash Flow | -37.79B | -33.74B | -24.78B | 4.42B | -48.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥100.70B | 7.35 | ― | 3.82% | -4.24% | 61.39% | |
78 Outperform | ¥657.15B | 17.63 | ― | 2.60% | 1.89% | -39.75% | |
68 Neutral | ¥582.20B | 23.26 | ― | 3.52% | 14.43% | 114.60% | |
66 Neutral | ¥614.70B | -13.88 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥363.85B | 21.92 | ― | 1.93% | <0.01% | -83.75% | |
47 Neutral | ¥5.04B | -4.73 | ― | 4.51% | 1.51% | -274.52% |